Hellman Jordan Management Company’s Dianthus Therapeutics DNTH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	$174K	Buy	27,570 +16,197	+142%	+$102K	0.3%	41
2022 Q3	$257K	Sell	11,373 -7,065	-38%	-$160K	0.45%	44
2022 Q2	$354K	Buy	+18,438	New	+$354K	0.48%	46